One-year mortality remains high in patients with prosthetic valve endocarditis

July 15, 2013

Prosthetic valve endocarditis (inflammation and infection involving the heart valves and lining of the heart chambers) remains associated with a high one-year mortality rate and early valve replacement does not appear to be associated with lower mortality compared with medical therapy according to a study by Tahaniyat Lalani, M.D., M.H.S., of the Naval Medical Center, Portsmouth, Virginia, and colleagues.

PVE occurs in approximately 3 percent to 6 percent of patients within five years of valve implantation and is associated with significant morbidity and mortality, according to the study background.

A total of 1,025 patients with PVE enrolled in the International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) between June 2000 and December 2006 met the study criteria. Of the study participants, 490 patients (47.8 percent) underwent early surgery, and 535 individuals (52.2 percent) received medical therapy alone.

According to the study results, compared with medical therapy, early surgery was associated with lower-in-hospital mortality in the unadjusted analysis and after controlling for bias. The lower mortality associated with surgery did not persist after adjustment for survivor bias.

"Approximately one-third of patients with PVE die within one year after diagnosis, with mortality strongly associated with other chronic illness, health care-associated infection, S aureus, and complications of PVE," the study concludes.

Explore further: Surgery improves endocarditis-induced heart failure survival rates

More information: JAMA Intern Med. Published online July 15, 2013. doi:10.1001/jamainternmed.2013.8203

Related Stories

Early surgery ups outcomes in infective endocarditis

June 28, 2012

(HealthDay) -- For patients with infective endocarditis and large vegetations, early surgery reduces death from any cause and embolic events, compared with conventional treatment, according to a study published in the June ...

Post-op mortality up for elderly with pre-heart op anxiety

January 11, 2013

(HealthDay)—Few elderly patients about to undergo cardiac surgery experience high levels of anxiety, but for those who do, there is a five-fold higher risk of postoperative major morbidity or mortality, according to research ...

Recommended for you

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.